{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:26Z","timestamp":1787020946432,"version":"build-2736575974"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["BIO-0139"],"award-info":[{"award-number":["BIO-0139"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PEER-0048-410"],"award-info":[{"award-number":["PEER-0048-410"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Science"},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"CIBERobn","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011997","name":"Foundation of the Spanish Society of Endocrinology and Nutrition","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011997","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Great Ormond Street Hospital Biomedical Research Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02040-w","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:08:25Z","timestamp":1751069305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets"],"prefix":"10.1186","volume":"13","author":[{"given":"Antonio C.","family":"Fuentes-Fayos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel E.","family":"G-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"S\u00e1nchez-Medianero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Apps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Flores-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana S.","family":"De la Rosa-Herencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gil-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Venegas-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio C\u00e1rdenas","family":"Ruiz-Valdepe\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura D.","family":"Herrera-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Solivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel D.","family":"Gahete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Soto-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"G\u00e1lvez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pedro","family":"Mart\u00ednez-Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa200","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noaa200","journal-title":"Neuro Oncol"},{"issue":"3","key":"2040_CR2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1210\/ENDREV\/BNAC035","volume":"44","author":"JR Apps","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP (2023) Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev 44(3):518\u2013538. https:\/\/doi.org\/10.1210\/ENDREV\/BNAC035","journal-title":"Endocr Rev"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1159\/000506904","volume":"110","author":"J Pedro Martinez-Barbera","year":"2020","unstructured":"Pedro Martinez-Barbera J, Andoniadou CL (2020) Biological Behaviour of Craniopharyngiomas. Neuroendocrinology 110:797\u2013804. https:\/\/doi.org\/10.1159\/000506904","journal-title":"Neuroendocrinology"},{"key":"2040_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/S40478-016-0287-6","volume":"4","author":"A H\u00f6lsken","year":"2016","unstructured":"H\u00f6lsken A et al (2016) Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun 4:20. https:\/\/doi.org\/10.1186\/S40478-016-0287-6","journal-title":"Acta Neuropathol Commun"},{"key":"2040_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0036-1588060","volume":"77","author":"J Lubuulwa","year":"2016","unstructured":"Lubuulwa J, Lei T (2016) Pathological and topographical classification of craniopharyngiomas: a literature review. J Neurol Surg Rep 77:121\u2013127. https:\/\/doi.org\/10.1055\/s-0036-1588060","journal-title":"J Neurol Surg Rep"},{"issue":"1","key":"2040_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5(1):1\u201319. https:\/\/doi.org\/10.1038\/s41572-019-0125-9","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2040_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/NG.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos PK et al (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46(2):161\u2013165. https:\/\/doi.org\/10.1038\/NG.2868","journal-title":"Nat Genet"},{"issue":"1","key":"2040_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/S12943-021-01468-7","volume":"20","author":"J He","year":"2021","unstructured":"He J et al (2021) Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing. Mol Cancer 20(1):168. https:\/\/doi.org\/10.1186\/S12943-021-01468-7","journal-title":"Mol Cancer"},{"issue":"5","key":"2040_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1470-2045(23)00162-6","volume":"24","author":"A Grossman","year":"2023","unstructured":"Grossman A, Kosmin M (2023) Craniopharyngiomas and proton beam therapy: worth the expense? Lancet Oncol 24(5):422\u2013423. https:\/\/doi.org\/10.1016\/S1470-2045(23)00162-6","journal-title":"Lancet Oncol"},{"key":"2040_CR10","doi-asserted-by":"publisher","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J (2020) Roles and mechanisms of alternative splicing in cancer \u2014 implications for care. https:\/\/doi.org\/10.1038\/s41571-020-0350-x","DOI":"10.1038\/s41571-020-0350-x"},{"key":"2040_CR11","doi-asserted-by":"publisher","unstructured":"Zhang Y, Qian J, Gu C, Yang Y (2021) Alternative splicing and cancer: a systematic review. Springer Nature. https:\/\/doi.org\/10.1038\/s41392-021-00486-7","DOI":"10.1038\/s41392-021-00486-7"},{"key":"2040_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.04.011","author":"E Wang","year":"2020","unstructured":"Wang E, Aifantis I (2020) RNA splicing and cancer. Trends in Cancer. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.011","journal-title":"Trends in Cancer"},{"issue":"3","key":"2040_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O (2023) RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer 23(3):135\u2013155. https:\/\/doi.org\/10.1038\/s41568-022-00541-7","journal-title":"Nat Rev Cancer"},{"key":"2040_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1476","author":"LM Urbanski","year":"2018","unstructured":"Urbanski LM, Leclair N, Anczuk\u00f3w O (2018) Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. WIREs RNA. https:\/\/doi.org\/10.1002\/wrna.1476","journal-title":"WIREs RNA"},{"key":"2040_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.07.010","author":"Y Shi","year":"2017","unstructured":"Shi Y (2017) The spliceosome: a protein-directed metalloribozyme. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2017.07.010","journal-title":"J Mol Biol"},{"issue":"2","key":"2040_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/J.MOLCEL.2019.09.017","volume":"76","author":"J Ule","year":"2019","unstructured":"Ule J, Blencowe BJ (2019) Alternative splicing regulatory networks: functions, mechanisms, and evolution. Mol Cell 76(2):329\u2013345. https:\/\/doi.org\/10.1016\/J.MOLCEL.2019.09.017","journal-title":"Mol Cell"},{"key":"2040_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1141","author":"JJ Turunen","year":"2013","unstructured":"Turunen JJ, Niemel\u00e4 EH, Verma B, Frilander MJ (2013) The significant other: splicing by the minor spliceosome. WIREs RNA. https:\/\/doi.org\/10.1002\/wrna.1141","journal-title":"WIREs RNA"},{"key":"2040_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003707","author":"CL Will","year":"2011","unstructured":"Will CL, L\u00fchrmann R (2011) Spliceosome structure and function. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a003707","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2040_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a032409","author":"C Yan","year":"2019","unstructured":"Yan C, Wan R, Shi Y (2019) Molecular mechanisms of pre-mRNA splicing through structural biology of the spliceosome. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a032409","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"2040_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/CDD.2016.91","volume":"23","author":"MP Paronetto","year":"2016","unstructured":"Paronetto MP, Passacantilli I, Sette C (2016) Alternative splicing and cell survival: from tissue homeostasis to disease. Cell Death Differ 23(12):1919. https:\/\/doi.org\/10.1038\/CDD.2016.91","journal-title":"Cell Death Differ"},{"issue":"3","key":"2040_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/WRNA.1760","volume":"14","author":"AJ Montero-Hidalgo","year":"2023","unstructured":"Montero-Hidalgo AJ et al (2023) Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment. Wiley Interdiscip Rev RNA 14(3):e1760. https:\/\/doi.org\/10.1002\/WRNA.1760","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2040_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.trsl.2022.07.005","volume":"251","author":"S Pedraza-Arevalo","year":"2023","unstructured":"Pedraza-Arevalo S et al (2023) Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. Transl Res 251:63\u201373. https:\/\/doi.org\/10.1016\/j.trsl.2022.07.005","journal-title":"Transl Res"},{"issue":"9","key":"2040_CR23","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1530\/ERC-22-0019","volume":"29","author":"MD Gahete","year":"2022","unstructured":"Gahete MD, Herman-Sanchez N, Fuentes-Fayos AC, Lopez-Canovas JL, Luque RM, Gahete MD (2022) Dysregulation of splicing variants and spliceosome components in breast cancer. Endocr Relat Cancer 29(9):R123\u2013R142. https:\/\/doi.org\/10.1530\/ERC-22-0019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2040_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00018-024-05515-6","volume":"82","author":"N Herm\u00e1n-S\u00e1nchez","year":"2024","unstructured":"Herm\u00e1n-S\u00e1nchez N, G-Garc\u00eda ME, Jim\u00e9nez-Vacas JM, Yubero-Serrano EM, L\u00f3pez-S\u00e1nchez LM, Romero-Mart\u00edn S, Raya-Povedano JL, \u00c1lvarez-Benito M, Casta\u00f1o JP, Luque RM, Gahete MD (2024) The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. Cell Mol Life Sci. 82(1):18. https:\/\/doi.org\/10.1007\/s00018-024-05515-6","journal-title":"Cell Mol Life Sci."},{"key":"2040_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2022.08.016","volume":"253","author":"JM Jim\u00e9nez-Vacas","year":"2023","unstructured":"Jim\u00e9nez-Vacas JM et al (2023) Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. Transl Res 253:68\u201379. https:\/\/doi.org\/10.1016\/j.trsl.2022.08.016","journal-title":"Transl Res"},{"key":"2040_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.trsl.2019.07.001","volume":"212","author":"JM Jim\u00e9nez-Vacas","year":"2019","unstructured":"Jim\u00e9nez-Vacas JM et al (2019) Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. Transl Res 212:89\u2013103. https:\/\/doi.org\/10.1016\/j.trsl.2019.07.001","journal-title":"Transl Res"},{"issue":"11","key":"2040_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-018-0085-0","volume":"15","author":"A Paschalis","year":"2018","unstructured":"Paschalis A et al (2018) Alternative splicing in prostate cancer. Nat Rev Clin Oncol 15(11):663\u2013675. https:\/\/doi.org\/10.1038\/s41571-018-0085-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2040_CR28","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/JC.2019-00021","volume":"104","author":"M Del R\u00edo-Moreno","year":"2019","unstructured":"Del R\u00edo-Moreno M et al (2019) Dysregulation of the splicing machinery is associated to the development of nonalcoholic fatty liver disease. J Clin Endocrinol Metab 104(8):3389\u20133402. https:\/\/doi.org\/10.1210\/JC.2019-00021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2040_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/S12276-022-00917-7","volume":"55","author":"JL L\u00f3pez-C\u00e1novas","year":"2023","unstructured":"L\u00f3pez-C\u00e1novas JL et al (2023) PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK\/AKT pathway via fibronectin 1 splicing. Exp Mol Med 55(1):132. https:\/\/doi.org\/10.1038\/S12276-022-00917-7","journal-title":"Exp Mol Med"},{"key":"2040_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/CTM2.1102","author":"JL L\u00f3pez-C\u00e1novas","year":"2022","unstructured":"L\u00f3pez-C\u00e1novas JL et al (2022) Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. Clin Transl Med. https:\/\/doi.org\/10.1002\/CTM2.1102","journal-title":"Clin Transl Med"},{"issue":"13","key":"2040_CR31","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.3390\/IJMS25136929","volume":"25","author":"ML Delgado","year":"2024","unstructured":"Delgado ML et al (2024) Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features. Int J Mol Sci 25(13):6929. https:\/\/doi.org\/10.3390\/IJMS25136929","journal-title":"Int J Mol Sci"},{"key":"2040_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101439","author":"MC V\u00e1zquez-Borrego","year":"2019","unstructured":"V\u00e1zquez-Borrego MC et al (2019) Splicing machinery is dysregulated in pituitary neuroendocrine tumors and is associated with aggressiveness features. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11101439","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2040_CR33","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1093\/brain\/awaa273","volume":"143","author":"AC Fuentes-Fayos","year":"2020","unstructured":"Fuentes-Fayos AC et al (2020) Splicing machinery dysregulation drives glioblastoma development\/aggressiveness: oncogenic role of SRSF3. Brain 143(11):3273\u20133293. https:\/\/doi.org\/10.1093\/brain\/awaa273","journal-title":"Brain"},{"issue":"1","key":"2040_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-022-02241-4","volume":"41","author":"AC Fuentes-Fayos","year":"2022","unstructured":"Fuentes-Fayos AC et al (2022) SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1\u00a0splicing and mTOR\/\u00df-catenin pathways imbalances. J Exp Clin Cancer Res 41(1):1\u201323. https:\/\/doi.org\/10.1186\/S13046-022-02241-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2040_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/HUMU.10172","volume":"21","author":"J B\u00e9nard","year":"2003","unstructured":"B\u00e9nard J, Douc-Rasy S, Ahomadegbe JC (2003) TP53 family members and human cancers. Hum Mutat 21(3):182\u2013191. https:\/\/doi.org\/10.1002\/HUMU.10172","journal-title":"Hum Mutat"},{"key":"2040_CR36","doi-asserted-by":"crossref","unstructured":"al, \u201cp63, a p53 Homolog at 3q27\u201329, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities,\u201d Mol Cell, vol 2, pp 305\u2013316, 1998","DOI":"10.1016\/S1097-2765(00)80275-0"},{"key":"2040_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10014-003-0141-y","volume":"20","author":"H Momota","year":"2003","unstructured":"Momota H et al (2003) Immunohistochemical analysis of the p53 family members in human craniopharyngiomas. Brain Tumor Pathol 20:73\u201377. https:\/\/doi.org\/10.1007\/s10014-003-0141-y","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"2040_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00483-4","volume":"11","author":"JH Kim","year":"2021","unstructured":"Kim JH et al (2021) In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas. Sci Rep 11(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-021-00483-4","journal-title":"Sci Rep"},{"issue":"5","key":"2040_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/S00401-018-1830-2","volume":"135","author":"JR Apps","year":"2018","unstructured":"Apps JR et al (2018) Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target. Acta Neuropathol 135(5):757\u2013777. https:\/\/doi.org\/10.1007\/S00401-018-1830-2","journal-title":"Acta Neuropathol"},{"key":"2040_CR40","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211754","author":"P Debnath","year":"2021","unstructured":"Debnath P, Huirem RS, Dutta P, Palchaudhuri S (2021) Epithelial-mesenchymal transition and its transcription factors. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20211754"},{"key":"2040_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2008.07.010","author":"BA Croker","year":"2008","unstructured":"Croker BA, Kiu H, Nicholson SE (2008) SOCS regulation of the JAK\/STAT signalling pathway. Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2008.07.010","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"2040_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12967-018-1539-Y\/FIGURES\/7","volume":"16","author":"S Wu","year":"2018","unstructured":"Wu S, Du Y, Beckford J, Alachkar H (2018) Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. J Transl Med 16(1):1\u20139. https:\/\/doi.org\/10.1186\/S12967-018-1539-Y\/FIGURES\/7","journal-title":"J Transl Med"},{"issue":"1","key":"2040_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MCB.19.1.1","volume":"19","author":"CV Dang","year":"1999","unstructured":"Dang CV (1999) c-Myc target genes involved in cell growth. Mol Cell Biol 19(1):1\u201311","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2040_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/01.RES.0000134920.10128.B4\/FORMAT\/EPUB","volume":"95","author":"N Takeda","year":"2004","unstructured":"Takeda N et al (2004) Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 95(2):146\u2013153. https:\/\/doi.org\/10.1161\/01.RES.0000134920.10128.B4\/FORMAT\/EPUB","journal-title":"Circ Res"},{"issue":"11","key":"2040_CR45","doi-asserted-by":"publisher","first-page":"111068","DOI":"10.1016\/J.ISCI.2024.111068","volume":"27","author":"T Matsuda","year":"2024","unstructured":"Matsuda T et al (2024) Deciphering craniopharyngioma subtypes: Single-cell analysis of tumor microenvironment and immune networks. iScience 27(11):111068. https:\/\/doi.org\/10.1016\/J.ISCI.2024.111068","journal-title":"iScience"},{"key":"2040_CR46","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2011-2187","author":"M Garcia-Lavandeira","year":"2012","unstructured":"Garcia-Lavandeira M et al (2012) Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET\/GFRA3 receptors. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/JC.2011-2187","journal-title":"J Clin Endocrinol Metab"},{"key":"2040_CR47","unstructured":"Ortiz Torres M, Shafiq I, Mesfin FB (2021) Craniopharyngioma. StatPearls Publishing"},{"key":"2040_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ebiom.2018.12.048","volume":"40","author":"J Dunn","year":"2019","unstructured":"Dunn J et al (2019) Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism. EBioMedicine 40:77\u201391. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.048","journal-title":"EBioMedicine"},{"issue":"6","key":"2040_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/J.ANNONC.2022.03.011","volume":"33","author":"AS Venkataramany","year":"2022","unstructured":"Venkataramany AS et al (2022) Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities. Ann Oncol 33(6):578\u2013592. https:\/\/doi.org\/10.1016\/J.ANNONC.2022.03.011","journal-title":"Ann Oncol"},{"key":"2040_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad548","author":"B Jin","year":"2023","unstructured":"Jin B et al (2023) MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkad548","journal-title":"Nucleic Acids Res"},{"key":"2040_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.008","author":"JM Jim\u00e9nez-Vacas","year":"2020","unstructured":"Jim\u00e9nez-Vacas JM et al (2020) Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer: SNRNP200, SRSF3 and SRRM1 as novel therapeutic targets for prostate cancer. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.008","journal-title":"EBioMedicine"},{"issue":"8","key":"2040_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/S41583-023-00717-6","volume":"24","author":"D Nikom","year":"2023","unstructured":"Nikom D, Zheng S (2023) Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat Rev Neurosci 24(8):457\u2013473. https:\/\/doi.org\/10.1038\/S41583-023-00717-6","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2040_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-023-02858-Z\/FIGURES\/3","volume":"42","author":"E Alors-P\u00e9rez","year":"2023","unstructured":"Alors-P\u00e9rez E et al (2023) Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. J Exp Clin Cancer Res 42(1):1\u201316. https:\/\/doi.org\/10.1186\/S13046-023-02858-Z\/FIGURES\/3","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2040_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12967-023-04754-8\/FIGURES\/5","volume":"21","author":"R Bl\u00e1zquez-Encinas","year":"2023","unstructured":"Bl\u00e1zquez-Encinas R et al (2023) Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. J Transl Med 21(1):1\u201316. https:\/\/doi.org\/10.1186\/S12967-023-04754-8\/FIGURES\/5","journal-title":"J Transl Med"},{"key":"2040_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.008","author":"JM Jim\u00e9nez-Vacas","year":"2020","unstructured":"Jim\u00e9nez-Vacas JM et al (2020) Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.008","journal-title":"EBioMedicine"},{"key":"2040_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108482108","author":"F Zammarchi","year":"2011","unstructured":"Zammarchi F et al (2011) Antitumorigenic potential of STAT3 alternative splicing modulation. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1108482108","journal-title":"Proc Natl Acad Sci"},{"key":"2040_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02602-z","author":"C Achour","year":"2023","unstructured":"Achour C, Prasad Bhattarai D, Groza P, Rom\u00e1n \u00c1-C, Aguilo F (2023) ARTICLE OPEN METTL3 regulates breast cancer-associated alternative splicing switches. Oncogene. https:\/\/doi.org\/10.1038\/s41388-023-02602-z","journal-title":"Oncogene"},{"issue":"4","key":"2040_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/EMBR.201337950","volume":"15","author":"A Zovoilis","year":"2014","unstructured":"Zovoilis A et al (2014) The expression level of small non-coding RNAs derived from the first exon of protein-coding genes is predictive of cancer status. EMBO Rep 15(4):402\u2013410. https:\/\/doi.org\/10.1002\/EMBR.201337950","journal-title":"EMBO Rep"},{"key":"2040_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112669","author":"A Alexander","year":"2023","unstructured":"Alexander A, Herz J, Calvier L (2023) Reelin through the years: from brain development to inflammation. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2023.112669","journal-title":"Cell Rep"},{"key":"2040_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/S12072-023-10562-5","author":"Y Xu","year":"2023","unstructured":"Xu Y et al (2023) Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression. Hepatol Int. https:\/\/doi.org\/10.1007\/S12072-023-10562-5","journal-title":"Hepatol Int"},{"issue":"18","key":"2040_CR61","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1158\/0008-5472.CAN-21-0307","volume":"81","author":"MP Labrecque","year":"2021","unstructured":"Labrecque MP et al (2021) RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer. Cancer Res 81(18):4736. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0307","journal-title":"Cancer Res"},{"key":"2040_CR62","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819858507","author":"C Yu","year":"2019","unstructured":"Yu C et al (2019) Characterization of the prognostic values of the NDRG family in gastric cancer. Therap Adv Gastroenterol. https:\/\/doi.org\/10.1177\/1756284819858507","journal-title":"Therap Adv Gastroenterol"},{"key":"2040_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.938470","author":"X Zhou","year":"2022","unstructured":"Zhou X, Khan S, Huang D, Li L (2022) V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2022.938470","journal-title":"Front Immunol"},{"issue":"4","key":"2040_CR64","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/2767-9764.CRC-22-0289","volume":"3","author":"L Lang","year":"2023","unstructured":"Lang L et al (2023) Adaptive c-Met-PLXDC2 signaling axis mediates cancer stem cell plasticity to confer radioresistance-associated aggressiveness in head and neck cancer. Cancer Res Commun 3(4):659. https:\/\/doi.org\/10.1158\/2767-9764.CRC-22-0289","journal-title":"Cancer Res Commun"},{"key":"2040_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1011171","author":"MI Khalil","year":"2023","unstructured":"Khalil MI et al (2023) HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer. PLoS Pathog. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1011171","journal-title":"PLoS Pathog"},{"key":"2040_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-022-04537-X","author":"Y Zhao","year":"2022","unstructured":"Zhao Y et al (2022) DGKZ promotes TGF\u03b2 signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGF\u03b2R2. Cell Death Dis. https:\/\/doi.org\/10.1038\/S41419-022-04537-X","journal-title":"Cell Death Dis"},{"key":"2040_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-022-28631-Y","author":"S Zhang","year":"2022","unstructured":"Zhang S et al (2022) GIT1 protects against breast cancer growth through negative regulation of Notch. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-022-28631-Y","journal-title":"Nat Commun"},{"issue":"5","key":"2040_CR68","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/J.GENDIS.2022.10.014","volume":"10","author":"M Qu","year":"2022","unstructured":"Qu M et al (2022) Sonic hedgehog signaling: alternative splicing and pathogenic role in medulloblastoma. Genes Dis 10(5):2013. https:\/\/doi.org\/10.1016\/J.GENDIS.2022.10.014","journal-title":"Genes Dis"},{"key":"2040_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/DIAGNOSTICS13091588","author":"A Serbis","year":"2023","unstructured":"Serbis A et al (2023) Predictive factors for pediatric craniopharyngioma recurrence: an extensive narrative review. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/DIAGNOSTICS13091588","journal-title":"Diagnostics (Basel)"},{"key":"2040_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/SREP19251","author":"E Macaeva","year":"2016","unstructured":"Macaeva E et al (2016) Radiation-induced alternative transcription and splicing events and their applicability to practical biodosimetry. Sci Rep. https:\/\/doi.org\/10.1038\/SREP19251","journal-title":"Sci Rep"},{"key":"2040_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/S41419-022-04526-0","author":"M Zanoni","year":"2022","unstructured":"Zanoni M et al (2022) Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma. Cell Death Dis. https:\/\/doi.org\/10.1038\/S41419-022-04526-0","journal-title":"Cell Death Dis"},{"issue":"7","key":"2040_CR72","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/S00381-020-04519-4","volume":"36","author":"E Moszczy\u0144ska","year":"2020","unstructured":"Moszczy\u0144ska E, Prokop-Piotrkowska M, Bogusz-W\u00f3jcik A, Grajkowska W, Szyma\u0144ska S, Szalecki M (2020) Ki67 as a prognostic factor of craniopharyngioma\u2019s recurrence in paediatric population. Child\u2019s Nerv Syst 36(7):1461. https:\/\/doi.org\/10.1007\/S00381-020-04519-4","journal-title":"Child\u2019s Nerv Syst"},{"key":"2040_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100963","author":"H Saeed","year":"2023","unstructured":"Saeed H, Leibowitz BJ, Zhang L, Yu J (2023) Targeting Myc-driven stress addiction in colorectal cancer. Drug Resist Updates. https:\/\/doi.org\/10.1016\/j.drup.2023.100963","journal-title":"Drug Resist Updates"},{"key":"2040_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02451-2","author":"W Tang","year":"2022","unstructured":"Tang W et al (2022) The miR-3648\/FRAT1-FRAT2\/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells. Oncogene. https:\/\/doi.org\/10.1038\/s41388-022-02451-2","journal-title":"Oncogene"},{"issue":"5","key":"2040_CR75","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/J.CELREP.2018.06.110","volume":"24","author":"I Miller","year":"2018","unstructured":"Miller I et al (2018) Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep 24(5):1105. https:\/\/doi.org\/10.1016\/J.CELREP.2018.06.110","journal-title":"Cell Rep"},{"issue":"2","key":"2040_CR76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/S00412-018-0659-8","volume":"127","author":"X Sun","year":"2018","unstructured":"Sun X, Kaufman PD (2018) Ki-67: more than a proliferation marker. Chromosoma 127(2):175. https:\/\/doi.org\/10.1007\/S00412-018-0659-8","journal-title":"Chromosoma"},{"issue":"10","key":"2040_CR77","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1158\/0008-5472.CAN-16-0707","volume":"77","author":"M Sobecki","year":"2017","unstructured":"Sobecki M et al (2017) Cell-cycle regulation accounts for variability in Ki-67 expression levels. Cancer Res 77(10):2722\u20132734. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0707","journal-title":"Cancer Res"},{"issue":"1","key":"2040_CR78","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/LEU.2014.144","volume":"29","author":"A Kurtovic-Kozaric","year":"2015","unstructured":"Kurtovic-Kozaric A et al (2015) PRPF8 defects cause missplicing in myeloid malignancies. Leukemia 29(1):126. https:\/\/doi.org\/10.1038\/LEU.2014.144","journal-title":"Leukemia"},{"key":"2040_CR79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/J.FREERADBIOMED.2021.02.038","volume":"167","author":"N Prescher","year":"2021","unstructured":"Prescher N, H\u00e4nsch S, Knobbe-Thomsen CB, St\u00fchler K, Poschmann G (2021) The migration behavior of human glioblastoma cells is influenced by the redox-sensitive human macrophage capping protein CAPG. Free Radic Biol Med 167:81\u201393. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2021.02.038","journal-title":"Free Radic Biol Med"},{"key":"2040_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13658","author":"E Alors-P\u00e9rez","year":"2024","unstructured":"Alors-P\u00e9rez E et al (2024) Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets. Mol Oncol. https:\/\/doi.org\/10.1002\/1878-0261.13658","journal-title":"Mol Oncol"},{"key":"2040_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/S13048-020-00685-W","author":"Q Xu","year":"2020","unstructured":"Xu Q, Deng B, Li M, Chen Y, Zhuan L (2020) circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382\u20135p\/PRPF8 axis. J Ovarian Res. https:\/\/doi.org\/10.1186\/S13048-020-00685-W","journal-title":"J Ovarian Res"},{"key":"2040_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3609789","author":"C Martelli","year":"2019","unstructured":"Martelli C et al (2019) Investigating the protein signature of adamantinomatous craniopharyngioma pediatric brain tumor tissue: towards the comprehension of its aggressive behavior. Dis Mark. https:\/\/doi.org\/10.1155\/2019\/3609789","journal-title":"Dis Mark"},{"key":"2040_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0832-0","author":"C Lindemann","year":"2011","unstructured":"Lindemann C, Hackmann O, Delic S, Schmidt N, Reifenberger G, Riemenschneider MJ (2011) SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-011-0832-0","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2040_CR84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/NEUONC\/NOY120","volume":"21","author":"AK Park","year":"2019","unstructured":"Park AK, Kim P, Ballester LY, Esquenazi Y, Zhao Z (2019) Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma. Neuro Oncol 21(1):59. https:\/\/doi.org\/10.1093\/NEUONC\/NOY120","journal-title":"Neuro Oncol"},{"key":"2040_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-019-10493-6","author":"D Henrik Heiland","year":"2019","unstructured":"Henrik Heiland D et al (2019) Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-019-10493-6","journal-title":"Nat Commun"},{"key":"2040_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.949509\/FULL","author":"Q Gao","year":"2022","unstructured":"Gao Q et al (2022) Integrative analyses identify HIF-1\u03b1 as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2022.949509\/FULL","journal-title":"Front Immunol"},{"issue":"3","key":"2040_CR87","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/CNCR.10281","volume":"94","author":"S Vidal","year":"2002","unstructured":"Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW (2002) Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer 94(3):738\u2013745. https:\/\/doi.org\/10.1002\/CNCR.10281","journal-title":"Cancer"},{"key":"2040_CR88","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/J.SURNEU.2006.05.047","volume":"66","author":"J Xu","year":"2006","unstructured":"Xu J, Zhang S, You C, Wang X, Zhou Q (2006) Microvascular density and vascular endothelial growth factor have little correlation with prognosis of craniopharyngioma. Surg Neurol 66:S30\u2013S34. https:\/\/doi.org\/10.1016\/J.SURNEU.2006.05.047","journal-title":"Surg Neurol"},{"issue":"4","key":"2040_CR89","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/J.1365-2559.2012.04297.X","volume":"61","author":"ST Qi","year":"2012","unstructured":"Qi ST, Zhou J, Pan J, Zhang C, Silky C, Yan XR (2012) Epithelial\u2013mesenchymal transition and clinicopathological correlation in craniopharyngioma. Histopathology 61(4):711\u2013725. https:\/\/doi.org\/10.1111\/J.1365-2559.2012.04297.X","journal-title":"Histopathology"},{"key":"2040_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2015.11.042","volume":"360","author":"M Chen","year":"2016","unstructured":"Chen M, Zheng SH, Liu Y, Shi J, Qi ST (2016) Periostin activates pathways involved in epithelial-mesenchymal transition in adamantinomatous craniopharyngioma. J Neurol Sci 360:49\u201354. https:\/\/doi.org\/10.1016\/j.jns.2015.11.042","journal-title":"J Neurol Sci"},{"key":"2040_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.995655","author":"Y Jia","year":"2022","unstructured":"Jia Y et al (2022) Immune infiltration in aggressive papillary craniopharyngioma: high infiltration but low action. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2022.995655","journal-title":"Front Immunol"},{"issue":"9","key":"2040_CR92","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/JNEN\/NLX061","volume":"76","author":"AM Donson","year":"2017","unstructured":"Donson AM et al (2017) Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma. J Neuropathol Exp Neurol 76(9):779. https:\/\/doi.org\/10.1093\/JNEN\/NLX061","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"2040_CR93","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.3892\/MMR.2017.6538","volume":"15","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhang C, Pan J, Chen L, Qi ST (2017) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Mol Med Rep 15(6):4123. https:\/\/doi.org\/10.3892\/MMR.2017.6538","journal-title":"Mol Med Rep"},{"issue":"4","key":"2040_CR94","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3892\/IJMM.14.4.505\/HTML","volume":"14","author":"M Mori","year":"2004","unstructured":"Mori M, Takeshima H, Ichi Kuratsu J (2004) Expression of interleukin-6 in human craniopharyngiomas: a possible inducer of tumor-associated inflammation. Int J Mol Med 14(4):505\u2013509. https:\/\/doi.org\/10.3892\/IJMM.14.4.505\/HTML","journal-title":"Int J Mol Med"},{"key":"2040_CR95","doi-asserted-by":"publisher","unstructured":"An NF-\u03baB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells, IGA Technology Services Srl, (2018) 20(6): 776\u2013787 https:\/\/doi.org\/10.1093\/neuonc\/nox234","DOI":"10.1093\/neuonc\/nox234"},{"key":"2040_CR96","doi-asserted-by":"publisher","unstructured":"Zhou L et al (2020) PI3K\/AKT signaling pathway mediates the proliferation, migration and invasion of papillary craniopharyngioma cells, https:\/\/doi.org\/10.21203\/RS.3.RS-119581\/V2","DOI":"10.21203\/RS.3.RS-119581\/V2"},{"key":"2040_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/S40478-024-01838-4","author":"JR Apps","year":"2024","unstructured":"Apps JR et al (2024) Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/S40478-024-01838-4","journal-title":"Acta Neuropathol Commun"},{"key":"2040_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/S13046-021-02153-9","author":"E Alors-Perez","year":"2021","unstructured":"Alors-Perez E et al (2021) Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/S13046-021-02153-9","journal-title":"J Exp Clin Cancer Res"},{"key":"2040_CR99","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2020.10.010","volume":"496","author":"JL L\u00f3pez-C\u00e1novas","year":"2021","unstructured":"L\u00f3pez-C\u00e1novas JL et al (2021) Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Lett 496:72\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.010","journal-title":"Cancer Lett"},{"issue":"3","key":"2040_CR100","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/JCMM.13440","volume":"22","author":"E Venegas-Moreno","year":"2018","unstructured":"Venegas-Moreno E et al (2018) Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly. J Cell Mol Med 22(3):1640. https:\/\/doi.org\/10.1111\/JCMM.13440","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2040_CR101","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1158\/1078-0432.CCR-19-2154","volume":"26","author":"MC Vazquez-Borrego","year":"2020","unstructured":"Vazquez-Borrego MC et al (2020) A somatostatin receptor subtype-3 (SST3) peptide agonist shows antitumor effects in experimental models of nonfunctioning pituitary tumors. Clin Cancer Res 26(4):957\u2013969","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2040_CR102","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.canlet.2015.01.037","volume":"359","author":"RM Luque","year":"2015","unstructured":"Luque RM et al (2015) Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas. Cancer Lett 359(2):299\u2013306. https:\/\/doi.org\/10.1016\/j.canlet.2015.01.037","journal-title":"Cancer Lett"},{"key":"2040_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104484","volume":"90","author":"AC Fuentes-Fayos","year":"2023","unstructured":"Fuentes-Fayos AC et al (2023) Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence. EBioMedicine 90:104484. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104484","journal-title":"EBioMedicine"},{"issue":"3","key":"2040_CR104","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/ijms26031341","volume":"26","author":"F Porcel-Pastrana","year":"2025","unstructured":"Porcel-Pastrana F, Montero-Hidalgo AJ, G-Garc\u00eda ME, Gil-Duque I, Prats-Escribano A, Gahete MD, Sarmento-Cabral A, Luque RM, Le\u00f3n-Gonz\u00e1lez AJ (2025) Cellular and molecular evidence of the synergistic antitumour effects of hydroxytyrosol and metformin in prostate cancer. Int J Mol Sci. 26(3):1341. https:\/\/doi.org\/10.3390\/ijms26031341","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2040_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/BIOINFORMATICS\/BTS635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS635","journal-title":"Bioinformatics"},{"issue":"15","key":"2040_CR106","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKW501","volume":"44","author":"SW Hartley","year":"2016","unstructured":"Hartley SW, Mullikin JC (2016) Detection and visualization of differential splicing in RNA-Seq data with JunctionSeq. Nucleic Acids Res 44(15):e127. https:\/\/doi.org\/10.1093\/NAR\/GKW501","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2040_CR107","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/BIOINFORMATICS\/BTP352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H et al (2009) The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25(16):2078. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTP352","journal-title":"Bioinformatics"},{"issue":"7","key":"2040_CR108","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/BIOINFORMATICS\/BTT656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30(7):923\u2013930. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTT656","journal-title":"Bioinformatics"},{"issue":"1","key":"2040_CR109","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/BIOINFORMATICS\/BTP616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139\u2013140. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTP616","journal-title":"Bioinformatics"},{"issue":"1","key":"2040_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-018-1417-1\/FIGURES\/4","volume":"19","author":"JL Trincado","year":"2018","unstructured":"Trincado JL et al (2018) SUPPA2: Fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions. Genome Biol 19(1):1\u201311. https:\/\/doi.org\/10.1186\/S13059-018-1417-1\/FIGURES\/4","journal-title":"Genome Biol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02040-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02040-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02040-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:08:28Z","timestamp":1751069308000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02040-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02040-w","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20211754","asserted-by":"subject"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Helsinki Declaration, of the World Medical Association, and with the approval of the Hospital Ethics Committee [Reina Sofia University Hospital (Cordoba, Spain); Virgen del Rocio University Hospital (Sevilla, Spain)]. Written informed consent was obtained from all individuals included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from all individuals included in the study enclose the use and consent for publication of data in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"142"}}